Prognostic value of quantitative assessment of macrophage content (CD68+) in the peritumoral zone of clear cell renal cell carcinoma
- 作者: Bobrov I.P.1, Lazarev A.F.2, Cherdantseva T.M.3, Klimachev I.V.2, Klimachev V.V.2, Myadelets M.N.2, Lepilov A.V.2, Dolgatov A.Y.2, Korsikov N.A.2, Dolgatova E.S.2, Lushnikova E.L.4, Bakarev M.A.4
-
隶属关系:
- Altai State Medical University
- Altay State Medical University
- Ryazan State Medical University
- Institute of Molecular Pathology and Pathomorphology
- 期: 卷 26, 编号 2 (2021)
- 页面: 49-56
- 栏目: Original Study Articles
- URL: https://bakhtiniada.ru/1028-9984/article/view/107125
- DOI: https://doi.org/10.17816/1028-9984-2021-26-2-49-56
- ID: 107125
如何引用文章
详细
AIM: To quantitatively analyze the macrophage distribution density (MF) of the peritumoral zone (PZ) of clear cell renal cell carcinoma (CCRCC) and determine the relationship of MF distribution density in PZ with clinical and morphological prognostic variables and postoperative survival of patients.
MATERIALS AND METHODS: The study included 52 patients with CCRCC, who had an average age of 56.7±0.8 years. Using monoclonal mouse antibodies for CD68 (clone PG-M1, DAKO), using an immunohistochemical method, macrophages were identified in the paraffin sections. The average amount of MF in the PZ was determined in three fields of view at ×400 magnification. For the PZ, the tissue was taken directly adjacent to the tumor to the conditionally unchanged kidney tissue.
RESULTS: The correlation analysis revealed that the density of the MF distribution in the CCRCC was interrelated with the stage of the disease (r=0.66; p=0.0001), size of the tumor node (r=0.52; p=0.0001), degree of anaplasia according to Fuhrman (r=0.80; p=0.0001), presence of metastases (r=0.62; 0.0001), and postoperative survival of patients (r=0.53; p=0.0001). However, there were no correlations with the gender (r=0.007; p=0.62) and age of the patients (r=0.03; p=0.83). With the number of MF in the PP <8.8, the cumulative proportion of survivors by the five-year term was 0.70 (70%). Moreover, when the number of MF in the PZ was ≥8.8, none of the patients lived to the five-year term, the cumulative proportion of survivors was 0 (log-rank-test, p=0.000001).
CONCLUSION: The density of MF distribution in PZ is interrelated with significant clinical and morphological parameters of CCRCC and is a predictor of the prognosis of five-year postoperative survival of patients. Thus, quantitative estimation of the number of MF in the PZ can be used in predicting the course of CCRCC along with the traditional classical forecasting factors.
作者简介
Igor Bobrov
Altai State Medical University
Email: ig.bobrov2010@yandex.ru
ORCID iD: 0000-0001-9097-6733
SPIN 代码: 2375-1427
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, BarnaulAlexander Lazarev
Altay State Medical University
Email: lazarev@arzs.ru
ORCID iD: 0000-0003-1080-5294
SPIN 代码: 1161-8387
MD, Dr. Sci. (Med.)
俄罗斯联邦, BarnaulTatyana Cherdantseva
Ryazan State Medical University
Email: cherdan.morf@yandex.ru
ORCID iD: 0000-0002-7292-4996
SPIN 代码: 3773-8785
MD, Dr. Sci. (Med.), Associate Professor
俄罗斯联邦, RyazanIlya Klimachev
Altay State Medical University
Email: k0222@yandex.ru
ORCID iD: 0000-0001-9889-9517
pathologist
俄罗斯联邦, BarnaulVladimir Klimachev
Altay State Medical University
Email: pathology_agmu@mail.ru
ORCID iD: 0000-0003-1586-252X
SPIN 代码: 8120-3059
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, BarnaulMikhail Myadelets
Altay State Medical University
Email: pathology_agmu@mail.ru
ORCID iD: 0000-0003-3256-6706
MD, Cand. Sci. (Med.), pathologist
俄罗斯联邦, BarnaulAlexander Lepilov
Altay State Medical University
Email: lepilov@list.ru
ORCID iD: 0000-0003-2477-4687
SPIN 代码: 7516-0963
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, BarnaulAndrey Dolgatov
Altay State Medical University
编辑信件的主要联系方式.
Email: adolgatov@yandex.ru
ORCID iD: 0000-0002-7677-4622
SPIN 代码: 2804-0011
MD, Cand. Sci. (Med.), Associate Professor
俄罗斯联邦, BarnaulNikolay Korsikov
Altay State Medical University
Email: nikkor94knaagmu@yandex.ru
ORCID iD: 0000-0002-0094-4656
俄罗斯联邦, Barnaul
Elena Dolgatova
Altay State Medical University
Email: esdol82@yandex.ru
ORCID iD: 0000-0002-6678-4472
俄罗斯联邦, Barnaul
Elena Lushnikova
Institute of Molecular Pathology and Pathomorphology
Email: pathol@inbox.ru
ORCID iD: 0000-0002-2614-8690
SPIN 代码: 3310-1175
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, NovosibirskMaxim Bakarev
Institute of Molecular Pathology and Pathomorphology
Email: pathol@inbox.ru
ORCID iD: 0000-0002-9614-592X
SPIN 代码: 3630-9977
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Novosibirsk参考
- Messex JK, Byrd CJ, Liou G-Y. Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer Development. Cells. 2020;9(4):919. doi: 10.3390/cells9040919
- Lazarev AF, Bobrov IP, Cherdantseva TM, et al. Mast cells and tumor growth. Siberian Juornal of oncology. 2011;46(4):59–63.
- Bobrov IP, Cherdantseva TM, Dolgatova ES, et al. Predictive Value of Quantitative Assessment B-Lymphocytes in the Peritumorous Zone in Renal Cell Carcinoma. Modern Problems of Science and Education. 2021;2:160–160. (In Russ). doi: 10.17513/spno.30739
- Cherdantseva TM, Bobrov IP, Avdalyan AM, et al. Mast cells in renal cancer: morphological correlations and prognosis. Bulletin of Experimental Biology and Medicine. 2017;163(6):768–773. (In Russ).
- Kazarcev AV, Cherdanceva TM, Bobrov IP, et al. Intratumoral Stromal Mast Cells in Renal Cell Carcinoma: Clinical and Morphological Comparisons. Russian Journal of Oncology. 2017;22(1):21–24. (In Russ). doi: 10.18821/1028-9984-2017-22-1-21-24
- Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett. 2009;123(2):97–102. doi: 10.1016/j.imlet.2009.02.011
- Sumitomo R, Hirai T, Fujita M, et al. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer. Exp Ther Med. 2019;18(6):4490–4498. doi: 10.3892/etm.2019.8068
- Song H, Wang T, Tian L, et al. Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis. J Cancer. 2019;10(22):5377–5387. doi: 10.7150/jca.31787
- Choi J, Gyamfi J, Jang H, Koo JS. The role of tumor-associated macrophage in breast cancer biology. Histol Histopathol. 2018;33(2):133–145. doi: 10.14670/HH-11-916
- Waniczek D, Lorenc Z, Snietura M, et al. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Arch Immunol Ther Exp (Warsz). 2017;65(5):445–454. doi: 10.1007/s00005-017-0463-9
- Sugimura K, Miyata H, Tanaka K, et al. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. J Surg Oncol. 2015;111(6):752–759. doi: 10.1002/jso.23881
- Hamada I, Kato M, Yamasaki T, et al. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res. 2002;22(6C):4281–4284.
- Santoni M, Massari F, Amantini C, et al. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother. 2013;62(12):1757–1768. doi: 10.1007/s00262-013-1487-6
- Toge H, Inagaki T, Kojimoto Y, et al. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages. Int J Urol. 2009;16(10):801–807. doi: 10.1111/j.1442-2042.2009.02377.x
- Hutterer GC, Pichler M, Chromecki TF, et al. Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma. Histopathology. 2013;63(3):309–315. doi: 10.1111/his.12163
补充文件
